BlackRock’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,066,337
| Closed | -$276M | – | 5152 |
|
|
2019
Q3 | $276M | Buy |
4,066,337
+1,513,588
| +59% | +$104M | 0.01% | 1159 |
|
|
2019
Q2 | $148M | Buy |
2,552,749
+121,950
| +5% | +$7.22M | 0.01% | 1640 |
|
|
2019
Q1 | $170M | Buy |
2,430,799
+239,110
| +11% | +$17.7M | 0.01% | 1528 |
|
|
2018
Q4 | $141M | Buy |
2,191,689
+154,253
| +8% | +$10.8M | 0.01% | 1570 |
|
|
2018
Q3 | $143M | Buy |
2,037,436
+34,464
| +2% | +$2.02M | 0.01% | 1721 |
|
|
2018
Q2 | $101M | Buy |
2,002,972
+68,691
| +4% | +$2.73M | ﹤0.01% | 1929 |
|
|
2018
Q1 | $60.5M | Sell |
1,934,281
-14,549
| -0.7% | -$483K | ﹤0.01% | 2158 |
|
|
2017
Q4 | $66.7M | Sell |
1,948,830
-249,049
| -11% | -$7.94M | ﹤0.01% | 2104 |
|
|
2017
Q3 | $70.5M | Sell |
2,197,879
-250,702
| -10% | -$7.91M | ﹤0.01% | 2065 |
|
|
2017
Q2 | $79.7M | Buy |
2,448,581
+61,789
| +3% | +$1.96M | ﹤0.01% | 1956 |
|
|
2017
Q1 | $75.2M | Buy |
2,386,792
+2,345,764
| +5,717% | +$69.4M | ﹤0.01% | 1964 |
|
|
2016
Q4 | $1.21M | Sell |
41,028
-2,965
| -7% | -$90.4K | ﹤0.01% | 1430 |
|
|
2016
Q3 | $1.27M | Sell |
43,993
-9,592
| -18% | -$267K | ﹤0.01% | 1393 |
|
|
2016
Q2 | $1.39M | Buy |
53,585
+6,594
| +14% | +$175K | ﹤0.01% | 1303 |
|
|
2016
Q1 | $1.16M | Buy |
46,991
+719
| +2% | +$19.7K | ﹤0.01% | 1305 |
|
|
2015
Q4 | $1.63M | Sell |
46,272
-7,800
| -14% | -$209K | ﹤0.01% | 1156 |
|
|
2015
Q3 | $1.14M | Hold |
54,072
| – | – | ﹤0.01% | 1244 |
|
|
2015
Q2 | $1.5M | Sell |
54,072
-3,300
| -6% | -$93.1K | ﹤0.01% | 1208 |
|
|
2015
Q1 | $1.75M | Buy |
57,372
+400
| +0.7% | +$12.7K | ﹤0.01% | 1128 |
|
|
2014
Q4 | $1.82M | Buy |
56,972
+56,600
| +15,215% | +$1.84M | ﹤0.01% | 1078 |
|
|
2014
Q3 | $11K | Hold |
372
| – | – | ﹤0.01% | 2695 |
|
|
2014
Q2 | $10K | Sell |
372
-58
| -13% | -$1.54K | ﹤0.01% | 2810 |
|
|
2014
Q1 | $11K | Hold |
430
| – | – | ﹤0.01% | 2677 |
|
|
2013
Q4 | $13K | Sell |
430
-42
| -9% | -$1.33K | ﹤0.01% | 2580 |
|
|
2013
Q3 | $14K | Buy |
472
+59
| +14% | +$1.97K | ﹤0.01% | 2463 |
|
|
2013
Q2 | $13K | Buy |
+413
| New | +$13.6K | ﹤0.01% | 2523 |
|
BlackRock's GHDX Position: Q4 2019 in Review
BlackRock sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 4,066,337 shares — an estimated $276M sold.
BlackRock first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $276M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- BlackRock reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- BlackRock sold 4,066,337 Genomic Health, Inc. shares in Q4 2019, an estimated $276M.
- BlackRock first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- BlackRock's Genomic Health, Inc. position peaked at $276M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.